70. Dirix, L.Y., et al., Avelumab, an anti- PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study. Breast Cancer Res Treat, 2017. Abbreviated T itle: STAT Trial Version Date : 08/17/2022 122 71. Nanda, R., et al., Pembrolizumab in Patients With Advanced Triple -Negative Breast Cancer: Phase Ib KEYNOTE- 012 Study. J C lin Oncol, 2016. 34(21): p. 2460-7.